Amniocentesis Medication

1. Woo R. A short history of amniocentesis, fetoscopy and chorionic villous sampling. History of Ultrasound in Obstetrics and Gynecology. Available at http://www.ob-ultrasound.net/amniocentesis.html.

2. ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol. 2007 Dec. 110(6):1459-67. [QxMD MEDLINE Link].

3. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologist. Number 43, May 2003. Management of preterm labor. Obstet Gynecol. 2003 May. 101(5 Pt 1):1039-47. [QxMD MEDLINE Link].

4. Intrapartum and Postpartum Care. Guidelines for Perinatal Care. American Academy of Pediatrics, American College of Obstetricians and Gynecologists; 2007.

5. Hankins, Clark, Cunningham, Gilstrap. Invasive Prenatal Diagnostic Procedures. Operative Obstetrics. Norwalk, CT: Appleton and Lange; 1995. 544-53.

6. Alfirevic Z, Navaratnam K, Mujezinovic F. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev. 2017 Sep 4. 9:CD003252. [QxMD MEDLINE Link].

7. Jenkins T, Wapner R. Prenatal Diagnosis of Congenital Disorders. Creasy, Resnik, Iams. Maternal Fetal Medicine. Philadelphia, PA: Elsevier Health Science; 2004. 235-80.

8. Simões M, Marques C, Gonçalves A, Pereira AP, Correia J, Castela J, et al. Amniocentesis in HIV pregnant women: 16 years of experience. Infect Dis Obstet Gynecol. 2013. 2013:914272. [QxMD MEDLINE Link]. [Full Text].

9. Yi W, Pan CQ, Hao J, Hu Y, Liu M, Li L, et al. Risk of Vertical Transmission of Hepatitis B after Amniocentesis in HBs Antigen-Positive Mothers. J Hepatol. 2013 Nov 19. [QxMD MEDLINE Link].

10. ACOG Practice Bulletin No. 97: Fetal lung maturity. Obstet Gynecol. 2008 Sep. 112(3):717-26. [QxMD MEDLINE Link].

11. Ke WL, Zhao WH, Wang XY. Detection of fetal cell-free DNA in maternal plasma for Down syndrome, Edward syndrome and Patau syndrome of high risk fetus. Int J Clin Exp Med. 2015. 8(6):9525-30. [QxMD MEDLINE Link].

12. Grati FR, Bajaj K, Malvestiti F, et al. The type of feto-placental aneuploidy detected by cfDNA testing may influence the choice of confirmatory diagnostic procedure. Prenat Diagn. 2015 Oct. 35(10):994-8. [QxMD MEDLINE Link].

Pedro Roca, MD, MPH, FACOG Fellow in Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Hershey Medical Center, Pennsylvania State University College of Medicine

Pedro Roca, MD, MPH, FACOG is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, American Medical Association, American Public Health Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Ronald M Ramus, MD Professor of Obstetrics and Gynecology, Director, Division of Maternal-Fetal Medicine, Virginia Commonwealth University School of Medicine

Ronald M Ramus, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, Medical Society of Virginia, Society for Maternal-Fetal Medicine

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article